Christian Fischer,Solomon D. Kattar,John M. Sanders
申请号：
US16433859
公开号：
US20190374526A1
申请日:
2019.06.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to Substituted Heterocyclic Compounds of Formula (I):R1—；R2—；R3—；R4 ； ； (I)and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, and R4 are as defined herein. The present invention also relates to compositions comprising at least one Substituted Heterocyclic Compound, and methods of using the Substituted Heterocyclic Compounds for inhibiting PRDM9 activity in a subject or for treating or preventing a disease mediated by PRDM9 activity.
